Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The included studies evaluated tirzepatida in populations with type 2 diabetes (T2DM), obesity or both, with a focus on outcomes such as reduction in glycated hemoglobin (HbA1c), loss of body weight and cardiovascular events
Both medications mimic the action of the GLP-1 hormone, offering similar benefits and side effects, including the potential for nausea and gastrointestinal issues
doi: 10.2147/IJN.S277190 73 HanK-YDugas-FordJSeikiMChangJ-HAzarDT
Bartalena L, Bogazzi F, Brogioni S, Grasso L, Martino E
( )
US$ 21.44
US$ 21.91
US$ 20.51
US$ 26.19
US$ 28.23
US$ 20.89
